BONAZZETTI, CECILIA MARIA
 Distribuzione geografica
Continente #
AS - Asia 2.257
NA - Nord America 807
EU - Europa 800
SA - Sud America 122
AF - Africa 74
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.081
Nazione #
US - Stati Uniti d'America 777
CN - Cina 640
VN - Vietnam 564
SG - Singapore 560
IT - Italia 428
HK - Hong Kong 147
KR - Corea 135
BR - Brasile 82
IN - India 61
DE - Germania 59
FR - Francia 49
NL - Olanda 49
JP - Giappone 46
CI - Costa d'Avorio 41
GB - Regno Unito 41
RU - Federazione Russa 32
FI - Finlandia 30
IE - Irlanda 24
AR - Argentina 23
AT - Austria 20
AU - Australia 17
CA - Canada 17
SE - Svezia 16
ZA - Sudafrica 15
IQ - Iraq 14
TW - Taiwan 13
TH - Thailandia 12
ID - Indonesia 11
PL - Polonia 11
BD - Bangladesh 10
PH - Filippine 10
MX - Messico 8
BG - Bulgaria 7
ES - Italia 7
TR - Turchia 7
JO - Giordania 6
PK - Pakistan 6
SA - Arabia Saudita 6
UA - Ucraina 5
CH - Svizzera 4
CO - Colombia 4
EC - Ecuador 4
PY - Paraguay 4
SC - Seychelles 4
BE - Belgio 3
CL - Cile 3
DK - Danimarca 3
LT - Lituania 3
NI - Nicaragua 3
TN - Tunisia 3
AL - Albania 2
CY - Cipro 2
EG - Egitto 2
MA - Marocco 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DZ - Algeria 1
ET - Etiopia 1
FJ - Figi 1
GH - Ghana 1
GR - Grecia 1
JM - Giamaica 1
MK - Macedonia 1
MU - Mauritius 1
NA - Namibia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.081
Città #
Singapore 408
Hefei 313
Ho Chi Minh City 162
Ashburn 156
Seoul 128
Bologna 127
Hong Kong 127
Hanoi 120
San Jose 91
Dallas 82
Santa Clara 64
Milan 45
Abidjan 41
Beijing 39
Tokyo 39
Council Bluffs 36
Los Angeles 35
Bengaluru 34
Da Nang 29
Castel Maggiore 26
Lauterbourg 25
Dublin 23
Boardman 19
New York 19
Rome 18
Haiphong 16
Frankfurt am Main 14
Munich 14
São Paulo 14
Vienna 14
Can Tho 13
Boydton 12
Helsinki 12
Buffalo 11
Johannesburg 11
Lappeenranta 11
Modena 11
Nuremberg 11
Redondo Beach 11
Adelaide 10
Quận Bình Thạnh 10
Amsterdam 9
Turin 9
Chicago 8
Florence 8
Shanghai 8
Tongling 8
Toronto 8
Warsaw 8
Bến Tre 7
Cesena 7
Guangzhou 7
Hải Dương 7
London 7
Paris 7
Sofia 7
Thái Nguyên 7
Turku 7
Amman 6
Bangkok 6
Chandler 6
Ha Long 6
Jakarta 6
Montreal 6
The Dalles 6
Berlin 5
Buenos Aires 5
Bắc Ninh 5
City of London 5
Denver 5
Falkenstein 5
Hyderabad 5
Naples 5
Orem 5
Pavia 5
Verona 5
Atlanta 4
Baghdad 4
Bhubaneswar 4
Biên Hòa 4
Budrio 4
Catanzaro 4
Ferrara 4
Genoa 4
Jeddah 4
Lunano 4
Moscow 4
Mumbai 4
Nanjing 4
Ninh Bình 4
Nizhniy Novgorod 4
Salt Lake City 4
San Lazzaro di Savena 4
Shenzhen 4
St Petersburg 4
Stockholm 4
Taichung 4
Vũng Tàu 4
Arcene 3
Bari 3
Totale 2.721
Nome #
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 253
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 247
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 193
Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, study 185
Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study 181
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 179
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 177
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development 172
Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection 167
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) 164
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study 159
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 156
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study 151
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections? 144
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 138
Long-term immune response after SARS-CoV2 vaccination in solid organ transplant recipients 135
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis 134
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 130
The impact of preservation fluid culture on graft site arteritis: a systematic review and metanalysis 128
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar? 119
Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes 111
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria 96
Association of Patients’ Epidemiological Characteristics and Comorbidities with Severity and Related Mortality Risk of SARS-CoV-2 Infection: Results of an Umbrella Systematic Review and Meta-Analysis 96
Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis 95
HHV8-related diseases in solid organ transplantation: a case series and systematic literature review 89
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 82
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients 77
The controversial bond between COVID-19 and bacterial superinfections 46
Pan-European Fragile Populations Cohort for COVID-19: What Worked, What Didn't, and Lessons Learned 44
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases 40
Implementation of a Bundle for the Management of Patients With Gram-Negative Bloodstream Infection: A Pre-Post Quasi-experimental Study 40
Impact of HCV eradication with direct-acting antiviral agents on serum gamma globulin levels in HCV and HCV/HIV coinfected patients 29
From clinical trials to daily practice: How to adequately administer sulbactam-durlobactam? alone or combined with imipenem? 26
Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: a valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections? 5
Totale 4.188
Categoria #
all - tutte 9.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 0 0 0 0 0 4 7 6 4
2022/2023104 3 5 1 3 25 7 1 7 27 5 11 9
2023/2024213 14 11 7 10 12 19 13 23 16 38 22 28
2024/2025864 31 65 52 63 82 31 44 50 27 67 139 213
2025/20262.986 310 493 342 324 216 93 352 123 549 184 0 0
Totale 4.188